Role of nuclear cardiology in patients with end stage renal disease

Patients with end stage renal disease (ESRD) with or without dialysis are at a higher risk for coronary artery disease. Currently, screening for coronary artery disease (CAD) is not a standard practice in ESRD patients. Diagnosing and treating renal patients with cardiovascular disease is still a major clinical dilemma as there is no clear-cut algorithm. Various diagnostic modalities are available for screening and diagnosis of cardiovascular disease in renal patients. These investigations seem to have varied sensitivity and specificity due to many complex metabolic changes occurring constantly in patients with renal disease. The aim of this review is to investigate the role ofr outinelyused cardiacinvestigations inr elationto renalpatients andto seehow nuclearcar diologycan helpin early diagnosis of cardiovascular disease in this group of patients.